Insmed reiterates BRINSUPRI at least $1B 2026 revenue target while targeting ARIKAYCE label expansion in H1 2027
Insmed, Inc. · PHARMACEUTICAL PREPARATIONS · Now $106.03
+10% in 3d after detection
Post-detection moves
1h
—
1d
-3.5%
3d
+10%
7d
+2.0%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS